Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet ...
The U.S. Food and Drug Administration (FDA) has approved Epkinly (epcoritamab-bysp) plus Revlimid (lenalidomide) and Rituxan ...
With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken ...
The FDA approved epcoritamab-bysp in combination with lenalidomide and rituximab for patients with relapsed or refractory ...
The FDA has approved a new type of medication to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), ...
The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...
Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...
Genmab's Epkinly receives traditional FDA approval for relapsed or refractory follicular lymphoma in combination and ...
Broadcast Retirement Network's Jeffrey Snyder discusses Over-the-Counter hearing aids with Towson University's Julie Norin, AuD. Jeffrey H. Snyder, Broadcast Retirement Network This morning on BRN, ...
The Food and Drug Administration is removing black box warnings from hormone replacement therapy products and approving new ...
The new approval that came from the USFDA makes it sure that the Linzess is safe and effective, bringing a sense of relief ...
"Shield" is the first FDA-approved blood test to screen for colorectal cancer. Could Trump destroy the Epstein files? New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback